Zhang John J Y, Lee Keng Siang, Voisin Mathew R, Hervey-Jumper Shawn L, Berger Mitchel S, Zadeh Gelareh
Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Bristol Medical School, Faculty of Health Sciences, University of Bristol, Bristol, UK.
Neurooncol Adv. 2020 Sep 18;2(1):vdaa111. doi: 10.1093/noajnl/vdaa111. eCollection 2020 Jan-Dec.
The goal of glioblastoma (GBM) surgery is to maximize the extent of resection (EOR) while minimizing postoperative neurological complications. Awake craniotomy (AC) has been demonstrated to achieve this goal for low-grade gliomas in or near eloquent areas. However, the efficacy of AC for GBM resection has not been established. Therefore, we aimed to investigate the outcomes of AC for surgical resection of GBM using a systematic review and meta-analysis of published studies.
Systematic searches of Ovid MEDLINE, Embase, Cochrane Controlled Register of Controlled Trials, and PubMed were performed from database inception to September 14, 2019 for published studies reporting outcomes of AC for GBM resection. Outcome measures analyzed included EOR and the event rate of postoperative neurological deficits.
A total of 1928 unique studies were identified. Fourteen studies reporting 278 patients were included in our meta-analysis. Mean age of patients was 46.9 years (95% confidence interval [CI]: 43.9-49.9). Early and late postoperative neurological deficits occurred in 34.5% (95% CI: 21.9-48.2) and 1.9% (95% CI: 0.0-9.2) of patients, respectively. Pooled percentage of gross total resection (GTR) was 74.7% (95% CI: 66.7-82.1), while the pooled percentage reduction in tumor volume was 95.3% (95% CI: 92.2-98.4).
Limited current evidence suggests that the use of AC for resection of supratentorial GBM is associated with a low rate of persistent neurological deficits while achieving an acceptable rate of GTR. Our findings demonstrate the potential viability of AC in GBM resection and highlight the need for further research on this topic.
胶质母细胞瘤(GBM)手术的目标是在将术后神经并发症降至最低的同时,使切除范围(EOR)最大化。清醒开颅手术(AC)已被证明可实现这一目标,适用于功能区或其附近的低级别胶质瘤。然而,AC用于GBM切除的疗效尚未得到证实。因此,我们旨在通过对已发表研究进行系统评价和荟萃分析,来研究AC用于GBM手术切除的结果。
从数据库建立至2019年9月14日,对Ovid MEDLINE、Embase、Cochrane对照试验注册库和PubMed进行系统检索,以查找报告AC用于GBM切除结果的已发表研究。分析的结果指标包括EOR和术后神经功能缺损的发生率。
共识别出1928项独特研究。14项报告了278例患者的研究被纳入我们的荟萃分析。患者的平均年龄为46.9岁(95%置信区间[CI]:43.9 - 49.9)。术后早期和晚期神经功能缺损分别发生在34.5%(95%CI:21.9 - 48.2)和1.9%(95%CI:0.0 - 9.2)的患者中。全切除(GTR)的合并百分比为74.7%(95%CI:66.7 - 82.1),而肿瘤体积的合并减少百分比为95.3%(95%CI:92.2 - 98.4)。
目前有限的证据表明,使用AC切除幕上GBM与持续性神经功能缺损发生率较低相关,同时能达到可接受的GTR率。我们的研究结果证明了AC在GBM切除中的潜在可行性,并强调了对该主题进行进一步研究的必要性。